Kinzal was developed for Bayer HealthCare for their highly innovative treatment for essential hypertension, Telmisartan. Being a two-syllable name, Kinzal is graphically impactful and distinctive.
This empty-vessel trade name has the ability to accommodate a variety of distinguishing descriptor suffixes, communicating innovation, efficacy and performance.